Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 3: role of site-specific mutations. 2004

Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
Dipartimento di Chimica, Università di Napoli Federico II, Complesso Universitario Monte S. Angelo, via Cintia, 80126 Napoli, Italy.

Proteolytic processing of HIV gp160 to produce gp120 and gp41 is performed by PC enzymes. This process is a prerequisite for the virus infectivity, since both gp120 and gp41 participate in the virus HIV-1 entry mechanism. The structure of the gp120/gp41 junction remains to be elucidated, and the structural features required for molecular recognition between HIV-1 gp160 and proteolytic enzymes have not been clarified. Furin is the best PC candidate for the gp160 proteolytic processing known to date. In previous studies on model peptides, we have shown the relevance of an N-terminal helix for the proper recognition of the gp160 processing site by furin. Here we analyze the effect of point mutations in peptides lacking a regular N-terminal helix. To this end, we present the structure-activity characterization of three peptide analogues of the HIV gp160 processing site that all present mutations in proline at positions P3 and/or P2', while sharing the same N-terminal sequence, containing helix-breaking D-amino acids. Conformational analysis of the peptides was carried out in solution by NMR techniques, and furin's efficiency in cleaving them was measured. Structural findings are presented and discussed in relation to the different exhibited activity.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations
D045683 Furin A proprotein convertase with specificity for the proproteins of PROALBUMIN; COMPLEMENT 3C; and VON WILLEBRAND FACTOR. It has specificity for cleavage near paired ARGININE residues that are separated by two amino acids. Dibasic Processing Enzyme,Furin Protein,Paired Basic Amino Acid Cleaving Enzyme,SPC1 Proteinase,Processing Enzyme, Dibasic
D019302 HIV Envelope Protein gp160 An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41. Envelope Glycoprotein gp160, HIV,HTLV-III gp160,env Protein gp160, HIV,gp160(HIV),HIV Envelope Glycoprotein gp160,gp160 Envelope Glycoprotein, HIV,HTLV III gp160,gp160, HTLV-III
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
July 1998, Biochemistry,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
March 1998, Biochemistry,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
December 1988, Proceedings of the National Academy of Sciences of the United States of America,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
January 1999, FEBS letters,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
November 1992, Nature,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
January 1991, Journal of acquired immune deficiency syndromes,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
November 1989, Journal of virology,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
July 2009, Journal of bioscience and bioengineering,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
March 1997, FEBS letters,
Lucia Falcigno, and Romina Oliva, and Gabriella D'Auria, and Massimiliano Maletta, and Monica Dettin, and Antonella Pasquato, and Carlo Di Bello, and Livio Paolillo
October 1992, AIDS research and human retroviruses,
Copied contents to your clipboard!